AI entity
All 1 tracked stories fall under one category: ai-research. Tumor Progression is most often covered alongside MIT, which appears in 1 of these 1 story. The 7 average consequence score is above the beat benchmark of 6.4 in the same window.
Last mentioned: Mar 10, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: ai-research. Tumor Progression is most often covered alongside MIT, which appears in 1 of these 1 story. The 7 average consequence score is above the beat benchmark of 6.4 in the same window. They are less corroborated than the beat average, carrying 2 original sources each against 2.2 for the same window. We currently track 1 AI story that mention Tumor Progression, all published on March 10, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 38 AI stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Tumor Progression. Shared-story counts are live from our verified record — not editorial picks.
MIT researchers have unveiled advanced predictive models designed to characterize the complex evolutionary trajectories of tumors. By leveraging machine learning to analyze multi-dimensional biological data, the team aims to forecast cancer progression and optimize personalized treatment interventions.
Tumor Progression is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
